Straits Times Index
3,306.02 +6.02 (+0.18%) S&P 500
5,464.62 -8.55 (-0.16%) Dow
39,150.33 +15.53 (+0.04%) Nasdaq
17,689.36 -32.24 (-0.18%) Bitcoin USD
64,110.67 -163.57 (-0.25%) CMC Crypto 200
1,321.90 -38.43 (-2.82%)
Prenetics Global Limited (PRE)
After hours:
Prenetics Global Limited
Unit 703-706, K11 Atelier King’s Road
728 King’s Road
Quarry Bay
Hong Kong
852 2210 9588
https://www.prenetics.com
Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 320
Description
Prenetics Global Limited, a genomics-driven health sciences company, engages in prevention, early detection, and treatment of cancer in Taiwan, Hong Kong, the United Kingdom, and internationally. It operates through two segments: Prevention and Diagnostics. The company offers CircleDNA, a consumer genetic testing product to offer DNA test. It also develops and commercializes Insighta, a multi-cancer early detection technology. In addition, the company is involved in genomic profiling of panels through ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests. Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk. Prenetics Global Limited is based in Quarry Bay, Hong Kong.
Corporate governance
Prenetics Global Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.
